USA Today: Why volunteer for a vaccine clinical trial? Duty, love and a willingness to experiment, participants say

First patient dosed in UC/UC Health vaccine trial says his son was a major motivation to volunteer

In a story about people who volunteer for COVID-19 vaccine trials, USA Today featured Jarelle Marshall, a 37-year-old IT professional from Cincinnati. He was the first patient to be dosed as part of the UC and UC Health trial of the Moderna COVID-19 vaccine trial. 

Moderna Vaccine trial 8/25/2020.  Mary Burns, PharmD, pharmacist.

A UC pharmacist prepares a dose for the COVID-19 vaccine trial. Photo/Colleen Kelley/UC Creative + Brand

Marshall said his 14-year-old son was a big part of his motivation to volunteer. "I always tell my son that what matters is what you do when people aren't looking," he said.

That's why when a friend asked him to participate in the trial, he didn't hesitate long. First, he asked for more information, which he forwarded to another friend, a doctor, to ask for advice. The doctor sent him a long text, telling him what to expect in the trial and why volunteers were important. Then came the kicker: Researchers need African-Americans like you. 

Read the entire article here, and read more about the UC/UC Health COVID-19 vaccine trial here

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Related Stories

1

Health care industry is hiring despite a job market that has cooled

April 16, 2026

The US labor market has cooled but the demand for health care workers, expecially skilled nurses, remains strong. Interviews with UC College of Nursing admininstrators Dr. Donna Green and Dr. Lindsay Davis were part of a WCPO segment on health care industry hiring.

2

AI advances in the liver disease field

April 15, 2026

MASH represents the advanced inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease), where fat accumulation in the liver triggers fibrosis and progressive liver injury. According to a recent MedCentral article, more AI-based clinical assessment tools in MASH are needed.

3

From spilled milk to super-resolution microscopy

April 15, 2026

University of Cincinnati student Eddie Gerstner will graduate this semester and enter medical school later this year. Born with a severe milk allergy, he has overcome numerous life-threatening reactions since.